Healthcare
Gimv invests €30m in Spineart
Investment marks Gimv's fourth investment in the healthcare space this year
Doctor's orders: A case study in reputational risk
PE investments in Nordic healthcare have become a controversial topic following the 'Carema scandal', which sparked ESG and transparency reforms
Doctor's orders: Avoid controversy, seek new opportunities
As GPs shy away from investment in healthcare provision, new opportunities are presenting themselves in other medically related sub-sectors
Ardian to acquire Lagarrigue Group
Azulis Capital exits after taking a majority stake during the secondary buyout in 2011
Pontifax Venture leads series-A round for Eyevensys
Research group has so far raised €10.8m in funding
Treating Europe's healthcare malaise
With Europe facing an ageing population and a sharp rise in long-term chronic illnesses, unquote" investigates private equity's role in solving the continent's healthcare conundrum
Doctor's orders: Taking the political pulse
Austerity measures are among the political developments resulting in an increasingly challenging environment for healthcare investors
Doctor's orders: Addressing Europe's healthcare shortfall
France, Germany and southern Europe are emerging as the continent's most active markets for PE investment in healthcare provision
Almi Invest et al. in SEK 23.8m round for Promimic
Chalmers Ventures and Karolinska Development also participated in the biotech investment
LSP leads €16.2m series-C for Vivasure Medical
Backers include Evonik Venture Capital, PanakУЉs Partners and Fountain Healthcare Partners
Bridgepoint's MédiPôle Partenaires buys Clinique Esquirol
BPI France also injected €95m into the private clinics group earlier this summer
DBAG buys Polytech
DBAG said in a statement it will invest up to €12m from its balance sheet
Innogest, Panakès lead €4.2m series-A for Seventeen
Funding round will allow the company to reach the commercialisation stage for its product
Calculus invests £3m in AIM-listed C4X Discovery
Funding round will enable the pharmaceuticals business to fund further drug development
HTGF et al. in Rigontec's €15m series-A extension
All previous backers reinvested in the third closing of the startup's series-A
CVC sells Quirónsalud to Helios for €5.76bn
Deal sees the GP sell its stake in the hospital group after a two-year holding period
IQ Capital leads £5.3m round for Fluidic Analytics
Investment will allow the UK biotech business to invest in its laboratory facilities
Technology Venture et al. in £2.6m round for Micrima
UK-based breast cancer screening company will launch its Maria products later this year
Isai sells Hospimedia to MNH Service
Isai invested €2m and acquired a 33% stake in the group in 2013
ProteoMediX raises CHF 5m from Altos Venture et al.
Altos has been backing the Zurich-based diagnostic tests company consistently since 2012
HQ Equita exits Windstar Medical in trade sale
German GP exits over-the-counter drugs maker less than two years after acquisition
Index Ventures and Creandum lead €6.1m round for Kry
Swedish digital health startup also raised funding from Berlin-based VC Project A Ventures
Deal in Focus: Waterland sticks to buy-and-build strategy with Median
The post-acute clinic business has made its 15th acquisition under the GP's tenure, with its latest bolt-on of AHG being one of the largest
Talde and Espiga back medical equipment producer Deltalab
Existing backer Talde, alongside new investor Espiga, will aim to boost the company expansion